Kornitzer Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$19.6M |
| 2 |
Insulet
PODD
|
+$18.5M |
| 3 |
Clorox
CLX
|
+$17.9M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$14.9M |
| 5 |
TransUnion
TRU
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$32.2M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$28.7M |
| 3 |
Amazon
AMZN
|
+$28.4M |
| 4 |
Intuit
INTU
|
+$26.6M |
| 5 |
FMC
FMC
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.17% |
| 2 | Healthcare | 17.4% |
| 3 | Industrials | 13.74% |
| 4 | Consumer Staples | 9.4% |
| 5 | Energy | 8.77% |
Similar funds
Kornitzer Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Kornitzer Capital Management held 517 positions worth $5.67B, up 1.8% from $5.57B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Kornitzer Capital Management withdrew a net $172M in Q2 2019, closing 24 positions and reducing 194 holdings. Its most notable exit was Worldpay, Inc., an estimated $23.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kornitzer Capital Management opened a new position in Elanco Animal Health worth $20.4M.
- Kornitzer Capital Management's largest Q2 2019 buy was Elanco Animal Health: 603,232 shares worth $20.4M.
- Kornitzer Capital Management added most to Clorox in Q2 2019, an estimated $17.9M increase.
- Kornitzer Capital Management's biggest Q2 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $32.2M.
- Kornitzer Capital Management fully exited Worldpay, Inc. in Q2 2019, selling an estimated $23.6M.
- Kornitzer Capital Management's ten largest holdings make up 13% of its $5.67B portfolio in Q2 2019.
- Kornitzer Capital Management opened 38 new positions and closed 24 in Q2 2019.
- Kornitzer Capital Management's portfolio value rose 1.8% quarter-over-quarter to $5.67B.
Based on Kornitzer Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.